915710-94-0

Basic information

• Product Name: tert‐butyl N‐[2‐(N‐hydroxycarbamimidoyl)ethyl]carbamate
• CAS NO: 915710-94-0
• Molecular Weight: 203.241
• Mol File: 915710-94-0.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: tert‐butyl N‐[2‐(N‐hydroxycarbamimidoyl)ethyl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert‐butyl N‐[2‐(N‐hydroxycarbamimidoyl)ethyl]carbamate(915710-94-0)
• EPA Substance Registry System: tert‐butyl N‐[2‐(N‐hydroxycarbamimidoyl)ethyl]carbamate(915710-94-0)

Safety Data

• Hazardous Substances Data: 915710-94-0(Hazardous Substances Data)

Upstream product

• 53588-95-7 3-<(tert-butoxycarbonyl)amino>propionitrile 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1201594-73-1 tert-butyl {2-[5-(4-bromophenyl)-1,2,4-oxadiazol-3-yl]ethyl}-carbamate 
• 218600-44-3 bardoxolone 

Relevant articles and documents

C17 POLAR-SUBSTITUTED HETEROAROMATIC SYNTHETIC TRITERPENOIDS AND METHODS OF USE THEREOF

Disclosed herein are compounds of the formula: (I) wherein the variables are defined herein. Also provided are pharmaceutical compositions thereof. In some aspects, the compounds and compositions provided herein may be used as antioxidant inflammation modulators. In some aspects, the present disclosure provides methods wherein the compounds and composition described herein are used for the treatment of diseases and disorders, including those associated with inflammation and cancer.

Tetrahydroquinoline Derivatives And Their Pharmaceutical Use

Tetrahydroquinoline compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.

FUSED BICYCLIC COMPOUNDS AS INHIBITORS FOR PI3 KINASE

The invention relates to compounds of formula (I) for the regulation of phosphoinositides 3-kinases activity and related diseases.